
|Articles|August 1, 2013
- LCGC North America-08-01-2013
- Volume 31
- Issue 8
Vol 31 No 8 LCGC North America August 2013 Regular Issue PDF
Click the title above to open the LCGC North America August 2013 regular issue, Vol 31 No 8, in an interactive PDF format.
Advertisement
Articles in this issue
about 13 years ago
Gradient Elution, Part VI: Ghost Peaksabout 13 years ago
Troubleshooting GC Selectivity, Resolution, and Baseline Issuesabout 13 years ago
How Reversed-Phase Liquid Chromatography Worksabout 13 years ago
Peaks of Interestabout 13 years ago
A Three-Pronged Template Approach for Rapid HPLC Method Developmentabout 13 years ago
Market Profile: Continuous Flow Analysis and Discrete AnalyzersAdvertisement
Advertisement
Advertisement
Trending on LCGC International
1
What Determines a Best-in-Class Antibody Drug Conjugate
2
Framing the Evolving Bioconjugate Landscape
3
What FDA’s 2026 Draft Guidance Means for Antibody Drug Conjugates
4
Important Analytical Measurements and Quality by Design for Bioconjugates
5




